VRTX logo

VRTX

Vertex Pharmaceuticals Incorporated

$424.00
-$2.76(-0.65%)
49
Overall
45
Value
54
Tech
--
Quality
Market Cap
$110.50B
Volume
2.22M
52W Range
$362.50 - $519.68
Target Price
$489.20

Latest News for VRTX

Buy These 3 Stocks Now, Say Five-Star Analysts – November 11, 2025
Vince Condarcuri14 days agoNov 11, 2025

Wondering which stocks to invest in right now? According to the following five-star Wall Street analysts, the stocks listed below are worth buying ......

Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Vertex Pharmaceuticals (VRTX)
Christine Brown15 days agoNov 10, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Climb Bio (CLYM – Research Report) and Vertex Pharma......

Barclays Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
TipRanks Auto-Generated Intelligence Newsdesk15 days agoNov 10, 2025

Barclays analyst Gena Wang maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $414.00. Wang covers the Healthcare s......

Vertex Pharmaceuticals (VRTX) Receives a Buy from TD Cowen
TipRanks Auto-Generated Intelligence Newsdesk21 days agoNov 04, 2025

TD Cowen analyst Phil Nadeau maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $525.00. The company’s shares closed......

Barclays Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX)
TipRanks Auto-Generated Intelligence Newsdesk21 days agoNov 04, 2025

Barclays analyst Gena Wang maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $414.00. The company’s shares closed ......

Vertex Pharmaceuticals Reports Strong Q3 2025 Results
TipRanks Auto-Generated Newsdesk21 days agoNov 04, 2025

Vertex Pharmaceuticals Inc. ( ($VRTX) ) has released its Q3 earnings. Here is a breakdown of the information Vertex Pharmaceuticals Inc. presented ......

Vertex Pharmaceuticals Advances Cystic Fibrosis Treatment with New Pediatric Study
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 clin......

Vertex Pharmaceuticals Advances Sickle Cell Disease Treatment with Exa-cel Study
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 clin......

Vertex Pharmaceuticals Advances VX-670 Study for Myotonic Dystrophy Type 1
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 1/2 cl......

Bernstein Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
TipRanks Auto-Generated Intelligence Newsdeska month agoOct 27, 2025

Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $471.00. The company’s share......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.

ABCD
1SymbolPriceChangeVol
2VRTX$424.00-0.6%2.22M
3
4
5
6

Get Vertex Pharmaceuticals Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.